Ultrasonic treatment for wounds

Information

  • Patent Grant
  • 7628764
  • Patent Number
    7,628,764
  • Date Filed
    Monday, August 13, 2001
    23 years ago
  • Date Issued
    Tuesday, December 8, 2009
    15 years ago
Abstract
A portable therapeutic device and method of use generate longitudinally propagating ultrasound and shear waves generated by such longitudinally propagating ultrasound to provide effective healing of wounds. A transducer having an operative surface is disposed substantially adjacent to the wound to emit ultrasound to propagate in the direction of the wound to promote healing. Reflections of the ultrasound by bone tissue, by skin layers, or by internally disposed reflective media propagate toward the wound as longitudinal waves, with shear waves generated by the longitudinal waves for the healing of the wound. A focusing element is used for focusing the propagation of the ultrasound at a predetermined angle toward the wound. The operative surface of the transducer may be annularly shaped to encircle the wound to convey the ultrasound and/or reflected ultrasound thereto.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


This disclosure relates to the non-invasive application of ultrasonic energy to enhance and/or accelerate the process of wound healing, and more particular, to the healing of wounds including ulcers, such as venous ulcers.


2. Description of the Related Art


Venous ulcers on human legs have proven difficult to treat, for example, because of the lack of vascularization in and around the wound.


The term “wound” for the purposes of “wound healing”, as used throughout the present disclosure, includes ulcers such as venous ulcers as well as burns, ulcerated wounds due to, for example, diabetes, surgical incisions or other surgical cuttings including stitched surgical cuttings, skin grafts, hair transplants, revascularization, bed sores, tissue dehiscence, and ligament and tendon repair and reconstruction. In general, as used throughout the present disclosure, the term “wound healing” encompasses addressing damage to, repair of, or restoration of soft tissue.


U.S. Pat. No. 4,530,360 to Duarte (hereafter “Duarte”), describes a basic therapeutic technique and apparatus for applying ultrasonic pulses from an ultrasonic applicator placed on the skin at a location adjacent a bone injury. Duarte gives a range of radio frequency (RF) signals for creating the ultrasound, ultrasonic power density levels, a range of duration of each ultrasonic pulse, and a range of ultrasonic pulse frequencies. The length of daily treatment is also described in Duarte. The Duarte patent is incorporated herein by reference.


U.S. Pat. Nos. 5,003,965 and 5,186,162, both to Talish and Lifshey (hereafter “Talish '965” and “Talish '162”, respectively) describe an ultrasonic delivery system in which the RF generator and transducer are both part of a modular applicator unit which is placed at the skin location. The signals controlling the duration of ultrasonic pulses and the pulse repetition frequency are generated apart from the applicator unit. Talish '965 and Talish '162 also describe fixture apparatus for attaching the applicator unit so that the operative surface is adjacent to the skin location. In one application described in Talish '965 and Talish '162, the skin is surrounded by a cast.


U.S. Pat. No. 5,211,160 to Talish and Lifshey (hereafter “Talish '160”) also describes a fixture apparatus which is mounted on uncovered body parts; i.e. without a cast or other medical wrapping. Talish '160 also describes various improvements to the applicator unit. Each of Talish '965, Talish '162, and Talish '160 is incorporated herein by reference.


U.S. patent application Ser. Nos. 08/391,109, 08/388,971, 08/389,148, and 08/367,471, entitled Gel Containment Structure, Locator Method and Apparatus, Apparatus for Ultrasonic Bone Treatment, and Acoustic System for Bone-Fracture Therapy, respectively, provides ultrasonic apparatus and methods which are applicable to wound healing. U.S. patent application Ser. Nos. 08/391,109, 08/388,971, 08/389,148, and 08/367,471 are incorporated herein by reference.


In general, an ultrasound carrier frequency between 20 kHz and 10 MHz coupled with a relatively low-frequency modulating signal, such as 5 Hz to 10 kHz, and a spatial peak temporal average acoustic intensity, such as an intensity less than about 100 milliwatts/cm2, should aid in and should be effective in wound healing.


Heretofore, such techniques have not been applied to heal wounds by internal application of ultrasound, such as using reflection of ultrasonic waves by reflection from internal tissue such as bone.


SUMMARY

It is herein recognized that both longitudinally propagating ultrasound and shear waves generated by a transducer mechanism and/or by such longitudinally propagating ultrasound provide effective healing of wounds.


A portable therapeutic device and method of use thereof for healing a wound includes a transducer having an operative surface, with the transducer, disposed substantially adjacent to the wound to emit ultrasound to propagate in the direction of the wound for the healing thereof. Reflections of the ultrasound by bone tissue and by skin layers propagate toward the wound as longitudinal waves for the healing thereof, and shear waves are generated by the longitudinal waves and/or the reflected longitudinal waves for the healing of the wound.


The transducer may include an axis and a focusing element for focusing the propagation of the ultrasound at a predetermined angle with respect to the axis, with the focused ultrasound propagating toward the wound for the healing thereof.


Alternative configurations of the operative surface of the transducer include an annularly shaped operative surface for emitting the ultrasound therefrom, with the wound encircled by the operative surface for receiving the ultrasound and/or reflected ultrasound.


A housing may be provided for positioning the transducer substantially adjacent to a portion of the skin substantially adjacent to the wound, and for causing the portion of the skin to form a cavity, with the operative surface of the transducer disposed in the cavity to emit the ultrasound to an internal surface of the wound for the healing thereof.


Reflective media may be internally disposed within the body having the wound for reflecting the ultrasound from the transducer to propagate toward the wound for the healing thereof. Fixture structures, extending about a portion of the body having the wound, may also be provided for positioning the transducer substantially adjacent to the skin substantially adjacent to the wound. The fixture structure may include an adjustable strap.


In other embodiments, the transducer may be a rod-shaped operative surface having an axis for emitting the ultrasound radially toward the wound for the healing thereof.


Using the disclosed therapeutic devices, wounds are safely and simply treated, with such wounds as venous ulcers responsive to therapeutic ultrasound to be healed effectively. Such therapeutic devices and methods of use provide for wound treatment by modest adaption of existing devices for delivering ultrasound in therapeutic settings.


In one embodiment, a device is provided for delivering an ultra-high-frequency carrier signal for low power excitation of an acoustic transducer which is acoustically coupled to a limb or other part of a living body. The transducer is positioned adjacent an external skin location in the vicinity of the external border of the wound on the skin to provide a surgical, non-invasive transcutaneous delivery of at least part of its acoustic energy directed from the external skin location toward a portion of a bone located within the body in the vicinity of the boundary of the wound internal to the body. The boundary of the wound internal to the body is also referred to herein as the internal or interior surface of the wound.


Once the acoustic energy enters the body, it passes into internal body tissue and/or fluids. The acoustic energy, in the form of ultrasonic pulses, is reflected off the surface of underlying bone or other ultrasound reflective material, and the reflected ultrasound travels toward at least part of the internal surface or underside of the wound. Healing of the wound at the internal surface by the generation of epithelial cells is enhanced via the acoustic stimulation.


Preferably, a low frequency signal which is present as a modulation of the carrier frequency is transmitted from the ultrasonic transducer, through interposed soft tissue, and onto the surface of the bone. The carrier wave incident on the bone surface, or other reflection surfaces in the body, is reflected toward the internal surface of the wound. When the carrier wave impinges the internal surface of the wound, at least a portion of the carrier wave is converted into therapeutically beneficial shear waves of acoustic energy, flooding a region of the internal surface of the wound. The shear waves increase vascularization at the internal surface of the wound, thus enhancing growth of epithelial cells. The epithelial cell growth represents healing of the wound. The technique thus promotes healing of the wound from the internal surface of the wound.


The number, position, and size of ultrasonic applicators used at the external skin location are chosen based on the size and position of the wound, and the relative position and proximity of the bone from which the ultrasonic waves are reflected. One or more ultrasonic therapy treatments per day, each having a duration of approximately 20 minutes, is suitable.





BRIEF DESCRIPTION OF THE DRAWINGS

The features of the disclosed therapeutic ultrasound apparatus and method will become more readily apparent and may be better understood by referring to the following detailed description of an illustrative embodiment of the present invention, taken in conjunction with the accompanying drawings, where:



FIG. 1 is a cut-away perspective view showing a device and method of use thereof for wound healing;



FIG. 2 is a side view of an embodiment of an ultrasound transducer;



FIG. 3 is a side cross-sectional view of the device using a focusing attachment;



FIG. 3A is a cut-away perspective view of an alternative embodiment of the transducer configured to have an annular shape and a woven fabric covering;



FIG. 4 is a frontal view of a typical wound disposed on a torso;



FIG. 5 is a cut-away perspective view of the wound healing device disposed near the wound in the torso;



FIG. 6 is a cut-away perspective view of the wound healing device applied to a wound in conjunction with a gel bladder;



FIG. 7 is a cut-away perspective view of the wound healing device causing an indentation of the torso to orient the transducer for healing the wound;



FIG. 8 is a cut-away perspective view of the wound healing device operating in conjunction with an internally disposed reflecting medium;



FIG. 9 is a cut-away perspective view of an alternative configuration of the wound healing device having an annular configuration and a woven fabric covering and operating in conjunction with an internally disposed reflecting medium;



FIG. 10 is a cut-away perspective view of an alternative configuration of the wound healing device having a rod-like configuration;



FIG. 11 is a cut-away perspective view of an alternative configuration of the wound healing device having an annular configuration without a woven fabric covering; and



FIG. 12 is a perspective view of an alternative configuration of the wound healing device attachable to a thigh for healing a wound thereupon.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring now in specific detail to the drawings, with like reference numerals identifying similar or identical elements, as shown in FIG. 1, the present disclosure describes an apparatus 10 and method of use thereof for wound healing, which includes an ultrasonic generator 12 and one or more ultrasonic applicators 14, which include ultrasonic transducers 16 known in the art, for applying ultrasonic waves 18, 20 to a wound 22, such as an ulcer. More than one applicator 14 or transducer 16 may be used to stimulate larger wounds, as needed. The spatial peak temporal average acoustic intensity of the applicators 14 is between about 5 mW/cm2 and about 100 mW/cm2. The carrier frequency and intensity of the ultrasonic treatment is selected by taking into account such factors as: (1) the amount of soft tissue interposed between the external skin location, where the ultrasonic applicator 14 is positioned, (2) the position and cross-section of the bone site 24 from which the ultrasonic waves 18 are reflected, (3) the amount of soft tissue interposed between the bone 26 and the internal surface 28 of the wound 20, and (4) the size, topography and medical characteristics of the internal surface 28 of the wound 20, and, consequently, shear waves or surface acoustic waves (SAW) and longitudinal waves to be generated at the site.


The carrier wave is modulated with an audio signal approximately between 5 Hz and 10 Khz. Low level ultrasound delivers a primary wave called the longitudinal wave 30, which is emitted by the transducer 16 of the applicator 14 as shown in FIG. 1. There are also shear waves or SAW 32 generated by the ultrasound from the transducer 16 which radiate outward along the skin surface. The primary longitudinal wave 30 is partially incident on a bone 26 in the body, and so is partially reflected at a reflection site 24 to generate a reflected portion 34, with the reflected portion 34 directed toward the internal surface 28 of the wound 22. The primary longitudinal wave 30 may also be reflected by other surfaces. For example, as shown in FIG. 1, the internal layer 36 of skin on the opposite side of a limb to the transducer 16 may provide a reflective surface to thus generate additional reflected longitudinal waves 38 directed from the opposite internal skin layer 36 to the wound 22.


When the reflected longitudinal waves 34, 38 impinge on the internal surface 28 of the wound 22, such reflected longitudinal waves 34, 38 are at least partially converted to shear waves or SAW 32 in and around the internal surface 28 of the wound 22, which enhance wound healing at the internal surface 28 by stimulating cell production by the mesenchymal line, thus promoting vascularization and epithelialization.


As shown in the illustrative embodiment in FIG. 1, the ultrasonic applicator 14, including the transducer 16 configured as a modular unit, is placed adjacent an external skin location 40 in the vicinity of the external border of the wound 22. A gel bladder 42, or alternatively a loose conducting gel or other ultrasound conducting media, is positioned between the transducer 16 and the external skin location 40. As shown in FIG. 1, the ultrasound which is transmitted into the soft tissue medium in the form of longitudinal waves 30 diverges as it moves toward the bone 26 or other surfaces such as the skin layer 36 providing reflection. The reflected ultrasound, in the form of longitudinal waves 34, 38, continues to diverge as it approaches the internal surface 28 of the wound 22, so that the ultrasonic treatment delivered to the general site of the wound 22 covers a relatively large region of the internal surface 28 of the wound 22.


Alternatively, as shown in FIG. 2, the transducer 16 may have an attachment, typically positioned between the operative surface 46 of the transducer 16 and the gel bladder 42, which acts as a focusing element to focus the ultrasound emitted from the operative surface 46 into the soft tissue. In another embodiment, the transducer 16 may be configured to have the focusing element integrally formed with the transducer 16. FIG. 3 shows a side view of the transducer housing of FIG. 2 showing the transducer 16 including the focusing element, illustratively embodied as the attachment 44. Thus, the ultrasound emitted from the transducer 16 in the form of a primary longitudinal wave 30 may be directed at an angle 48 with respect to an axis 50 associated with the transducer and thence toward the bone 26 or other reflective surfaces when the ultrasound enters the soft tissue. The reflected waves 34, 38 also remain relatively focused.


The reflected longitudinal waves 34, 38 may generate respective sets of shear waves or SAW for providing a combined therapeutic treatment to the wound 22. As shown in FIG. 3, the reflected longitudinal wave 34 created by reflection of the primary longitudinal wave 30 off the bone 26 is incident on a portion of the internal surface 28 of the wound 22, thus creating a first set of shear waves 52. The reflected longitudinal wave 38 created by the reflection of the primary longitudinal wave 30 off the opposite side layer 36 of tissue is incident on a separate portion of the wound 22, thus creating a second set of shear waves 54. In addition to this technique, the angle 48 of the ultrasonic emission may be swept and/or modified, either physically or electronically, so that different regions of the internal wound surface 28 may be treated.


In either technique, two or more transducers may be used, as determined by the size, length, etc. of the wound 22. Generally, multiple transducers may be provided at a number of external skin locations around the wound 22 in order to increase the effectiveness of the ultrasonic therapy reflected to the internal surface 28 of the wound 22.


In the illustrative embodiments of FIGS. 1-3, the ultrasonic head module of the ultrasonic applicator 14 includes the transducer 16 of an ultrasonic treatment apparatus. For clarity, the fixture structure which holds the head module adjacent the external skin location 40 is omitted. Also omitted are the electronics and other features which ultimately provide the excitation signals for the transducer 16. These are described in further detail in the above-referenced patents and patent applications, which have been incorporated by reference.


Alternatively, or in conjunction, the at least one ultrasonic applicator 14 may be moved, or may be configured to be movable, to a different external skin location adjacent the wound 22 in order to provide treatment to various portions of the wound 22. Varying the position of the at least one ultrasonic applicator, including moving the transducer 16 circularly or linearly along the skin, also provides treatment of varying intensity at portions of the wound 22.


The transducer 16 itself may also be configured to vibrate with respect to a given external skin location, so that the longitudinal waves 30 generated therefrom and transmitted through the soft tissue are more uniform, thus providing more uniform treatment, including more uniform shear waves, at the internal wound surface 28 where the reflected longitudinal waves 34, 38 impinge. The transducer 16 may be made to vibrate with respect to a housing (not shown in FIGS. 1-3 for clarity) which holds the transducer 16 adjacent an external skin location to accomplish such uniformity of longitudinal waves 30.


The focusing of ultrasonic waves described with respect to FIGS. 2-3 above is illustratively shown with a substantially planar operative surface 46 and a substantially conical attachment 44. In alternative embodiments, the focusing of ultrasonic waves may be provided by configuring the transducer 16 with non-planar surfaces such as non-planar operative surfaces or non-planar segments to generate and emit ultrasound with different propagation characteristics in order to allow differing patterns and intensities of ultrasonic waves to be transmitted toward the internal surface 28 of the wound 22. This provides a variety of therapeutic ultrasonic stimulation and treatment at the internal surface 28.


For example, the transducer segments may be pie shaped, annular rings, or other configurations, which may be activated separately or in unison. Alternatively, or in conjunction, the transducer 16 may be provided with a modal converter or transducer lens, which may also change the pattern of the ultrasound emitted from the transducer 16.


The carrier frequency and/or the modulating frequency may also be varied or swept through a range of frequencies in order to provide a variety of treatments to the internal wound surface 28. The frequencies may be varied either in a continuous manner, or discrete changes may be made in the applied frequency. Varying the carrier and/or modulating frequency is especially useful in applying ultrasonic treatment to promote a variety of stages of cell regeneration in approximately the same region during the same therapy session.


In an alternative embodiment, FIG. 3A illustrates treatment of a wound 22 such as a venous ulcer as in FIGS. 1-3, but utilizing an annular-shaped transducer 56 having a curved operative surface 58 (shown in a cut-away perspective view in FIG. 3A) composed of a composite piezoelectric material attached by a connector 60 to an ultrasonic generator (not shown in FIG. 3A), in which the composite piezoelectric material disposed in a woven fabric 62 or a semi-permeable member provides ultrasonic conductivity between the transducer 56 and the skin of the patient. The woven fabric 60 may have either a hard or a pliable construction, and may be composed of material conductive of ultrasound. Alternatively, the woven fabric 60 may be porous for retaining and releasing ultrasound conductive gel.


The transducer 56 is cut or constructed to surround the external surface of the wound 22. When the appropriate RP signals are applied, the composite piezoelectric material of the transducer 56 emits ultrasonic waves having the therapeutic parameters previously described. Primary longitudinal waves 64, 66 are emitted from the composite piezoelectric material into the body, as shown in FIG. 3A, and reflected from the surface of the bone 26 or from other reflective interfaces, to generate reflected longitudinal waves 68, 70, respectively, which are directed onto the internal surface 28 of the wound 22, thus creating therapeutic shear waves 72, 74, respectively. It is understood that the composite piezoelectric material may completely surround the wound 22; thus, the primary longitudinal waves 64, 66 are emitted from around the entire wound, reflected from the reflecting material, and incident on the internal surface 28 of the wound 22, thereby flooding the internal surface 28 of the wound 22 with the induced shear waves 72, 74.


While the embodiments of the present invention described above refer to the reflection of a primary longitudinal wave from a bone to an internal surface of a wound, the present invention also encompasses delivery of ultrasound to the internal surface of the wound where there is no bone or other reflecting surface in the vicinity of the wound, as described below in further detail with reference to FIGS. 4-11.



FIG. 4 illustrates the front of a male torso 76 having a wound 78 on the stomach. The views illustrated in FIGS. 5-11 are cross-sectional views of FIG. 4 taken across lines 5-5. As shown in FIG. 5, a transducer 80 is positioned in a transducer housing 82 disposed upon the external skin of the torso 76 adjacent to the external border of the wound 78, and a longitudinal wave 84 emitted from the transducer 80 penetrates far into the body before it is reflected off a surface internal to the torso 76 such as the spine or any internal organs such as the lungs, stomach, or intestines, which may contain gases such as air, with reflected longitudinal waves then directed onto the internal surface 86 of the wound 78. This is especially true when the person is overweight, or when the cross-section of available reflecting surfaces is small and/or uneven. The longitudinal wave 84 may provide some therapeutic healing of the wound 78, but the intensity of the reflected wave incident on the internal surface 86 of the wound 78 may be too attenuated to provide the necessary therapeutic treatment.



FIG. 6 shows an alternative method and embodiment of treating such wounds of the torso 76, in which a gel bladder 88 is interposed between the external surface of the wound 78 and the operative surface of the transducer 80. The longitudinal wave 84 emitted from the transducer 80 travels directly through the gel bladder 88 and into the wound 78, thus creating a shear wave 90 when the longitudinal wave 84 is incident on the internal surface of the wound 78. The gel bladder 88 is to be sterile, especially if the wound 78 is open, and may be impregnated with medication, such as an antibacterial ointment, which flows into the wound 78 and/or its surface during the ultrasonic treatment.



FIG. 7 illustrates another method and device for treating the wound 78 of a torso 76, in which the transducer 80 is pressed against the external surface of the lower torso, such as approximately adjacent the stomach, to be positioned near the wound 78. By pressing the transducer housing 82 against the external region of the stomach, a local indentation 92 is created. The transducer housing 82 may be turned as it is pressed inward, so that the operative surface 94 of the transducer 80 is directed in the general direction toward the internal surface 96 of the wound 78 within the indentation 92. As shown, the longitudinal wave 98 emitted is incident directly on at least a portion of the internal surface 96 of the wound 78, thus inducing therapeutic shear waves 100. If a specially configured transducer, or alternatively a transducer attachment 102, is used, such as shown in FIG. 3, for focusing the ultrasound in a specific direction, the longitudinal wave 98 may be emitted off of a center axis 104 of the transducer 80, for example, in a direction toward the internal surface 96 of the wound 78, without the need for turning the transducer housing 82 as it is pressed against the skin.



FIG. 8 illustrates another method and device for treating a wound 78, in which a reflecting medium 106 is inserted into the body in the proximity of the internal surface 96 of the wound 78. The properties of the reflecting medium 106 provide for the reflection of the longitudinal wave 108 toward the internal surface 96 of the wound 96, as if a bone were present, such as described above with reference to FIGS. 1-3A. The reflecting medium 106 may be composed of a variety of materials, and may be fixed in the body or inserted temporarily. For example, the reflecting medium 106 may be a metallic plate, a gas filled pouch, or other quasi-permanent inserts. The reflecting medium 106 may be also be, for example, a contrast agent composed of, for example, bubbles in a gelatin, which is injected intravenously prior to the treatment. In one embodiment, the contrast agent may be absorbable by the body in a relatively short period, thus the contrast agent acts as a temporarily inserted reflecting medium.


An inserted reflecting medium 106, as described with respect to FIG. 8 above, performs particularly well in conjunction with a piezoelectric ultrasonic material or device. As shown in FIG. 9, the piezoelectric ultrasonic device 110 may be embodied as the device 56 described above with respect to FIG. 3A. The piezoelectric ultrasonic device 110 may be configured to surround the exterior boundary of the wound 78. As shown in FIG. 9, illustrative examples of the longitudinal waves 112, 114 generated from the piezoelectric ultrasonic device 110 surrounding the wound 78 are reflected off of an internally disposed medium 116 and onto the internal surface 96 of the wound 78, thereby generating therapeutic shear waves (not shown in FIG. 9) at the internal surface 96 of the wound 78. It is understood that the piezoelectric ultrasonic device 110 completely surrounds the wound 78; thus, longitudinal waves not limited to the illustrative examples of longitudinal waves 112, 114 are emitted around the entire wound 78, reflected from the reflecting material 116, and incident on the internal surface 96 of the wound 78, to flood the internal surface 96 of the wound 78 with induced shear waves.


In an alternative embodiment shown in FIG. 10, an ultrasonic transmitting rod 118 is provided which emits at least one longitudinal wave 120 radially from the axis of the ultrasonic transmitting rod 118. The rod 118 may be composed of, for example, a composite piezoelectric material, and the rod 118 is secured to the patient by a harness apparatus 122, 124 such that the rod 118 is pressed against the skin adjacent the wound 10, and a portion of the longitudinal wave 120 is incident on the internal surface 96 of the wound 78, thus inducing therapeutic shear waves (not shown in FIG. 10).


In another alternative embodiment shown in FIG. 11, an ultrasonic transmitting ring 126 is provided which emits longitudinal waves 128, 130 radially from the surface of the ring 126. The ring may be composed of, for example, a composite piezoelectric material, and may be configured in a manner similar to the piezoelectric ultrasonic devices 56 and 110 in FIGS. 3A and 9, respectively, without the woven fabric to act as an ultrasonic conductor. Accordingly, ultrasonic conductive gel may be used with the ring 126 of FIG. 11. With the ring pressed against the skin surrounding the wound 78, a portion of the longitudinal waves 128, 130 emitted from the ring 126 is incident on the internal surface 96 of the wound 78, thus inducing therapeutic shear waves 132, 134. It is understood that the ring 126 may be configured to completely surrounds the wound 78; thus, longitudinal waves including the illustrative longitudinal waves 128, 130 are emitted from around the entire wound 78 and incident on the internal surface 96 of the wound 78, to flood the internal surface 96 of the wound 78 with induced shear waves 132, 134.


In an alternative configuration shown in FIG. 12, the wound healing device 136 includes a transducer 138 positioned in a housing 140 which is secured by an adjustable securing structure 142 to a thigh for healing a wound 78 thereupon, with the transducer 138 emitting longitudinal ultrasonic waves 144 which generate shear waves (not shown in FIG. 12) upon contact with the internal surface of the wound 78. In an illustrative embodiment, the adjustable securing structure 142 shown in FIG. 12 includes an adjustable strap 146 having a first portion 148 engaging a second portion 150 using hook and link fasteners, such as “VELCRO”. Alternatively, a belt with a buckle and notches may be used, or a sterile adhesive strip for adhering to the thigh.


As noted above, the term “wound” as used herein, has a broad meaning, generally encompassing addressing damage to, repair of, or restoration of soft tissue. The present invention may be used, for example, to prevent surgical adhesions, by stimulating the proper repair of surgical incisions. It may also prevent or arrest wound dehiscence, by promoting vascularization at the surfaces adjacent surgical incisions. It may also be used in cosmetic surgery, for example, by enhancing the healing of hair transplants, or by directly stimulating regeneration of cells.


Accordingly, modifications such as those suggested above, but not limited thereto, are to be considered within the scope of the invention.

Claims
  • 1. A method for promoting healing of a wound comprising: determining a position for an ultrasonic transducer in the vicinity of the wound at which ultrasonic waves transmitted from the ultrasonic transducer in a first direction are reflected off a surface of a body toward an interior surface of the wound such that a sufficient level of the reflected ultrasonic waves contact the wound to promote healing thereof;positioning the ultrasonic transducer at the determined position in the vicinity of the wound; andemitting ultrasonic waves from the ultrasonic transducer in the first direction such that the emitted ultrasonic waves are reflected off the surface of the body toward the interior surface of the wound such that the sufficient level of the reflected ultrasonic waves contact the wound to promote healing thereof.
  • 2. The method of claim 1 wherein the body surface comprises bone tissue.
  • 3. The method of claim 1 wherein positioning the transducer includes positioning the transducer substantially adjacent a first layer of skin and wherein the body surface comprises a second layer of skin.
  • 4. The method of claim 1 wherein the determined location is adjacent to the wound.
  • 5. The method of claim 1 wherein the first direction is angled with respect to an axis that is normal to an operative surface of the ultrasonic transducer.
  • 6. The method of claim 1 wherein the ultrasonic waves transmitted from the ultrasonic transducer in the first direction do not encounter the interior surface of the wound until after reflecting off the surface of the body.
  • 7. The method of claim 1 wherein the ultrasonic waves emitted from the ultrasonic transducer are focused in the first direction.
  • 8. The method of claim 1 wherein the ultrasonic transducer is toroidal, and wherein positioning the ultrasonic transducer comprises surrounding the wound.
  • 9. The method of claim 1 wherein the surface of the body comprises skin tissue.
  • 10. The method of claim 1 wherein the body comprises an internally disposed fabricated reflective medium.
  • 11. The method of claim 1 wherein positioning the transducer at the determined position comprises disposing the transducer proximate a first outer skin surface portion, the wound being located at second outer skin surface portion proximate the first outer skin surface portion such that ultrasonic waves emitted from the ultrasonic transducer pass through the first outer skin surface portion to the surface of the body.
Parent Case Info

The present application is a continuation of Ser. No. 09/273,214, filed Mar. 19, 1999, now U.S. Pat. No. 6,190,336, which is a divisional of U.S. application Ser. No. 08/886,217, filed Jul. 1, 1997, now U.S. Pat. No. 5,904,659, which is a continuation of U.S. application Ser. No. 08/799,240, filed Feb. 14, 1997, now abandoned.

US Referenced Citations (344)
Number Name Date Kind
1063782 Dickey et al. Jun 1913 A
1604870 Asman Oct 1926 A
2914829 Willermain Dec 1959 A
2920853 Bufogle Jan 1960 A
3117571 Fry et al. Jan 1964 A
3134451 Hanssen May 1964 A
3193034 Hutchinson et al. Jul 1965 A
3241375 Canzoneri Mar 1966 A
3304036 Davis Feb 1967 A
3310049 Clynes Mar 1967 A
3433663 Underwood Mar 1969 A
3499437 Balamuth Mar 1970 A
3521225 Kursman et al. Jul 1970 A
3550586 Balamuth Dec 1970 A
3575050 Lynnworth Apr 1971 A
3594993 Heyse Jul 1971 A
3664626 Sneller May 1972 A
3701352 Bosworth Oct 1972 A
3714619 Morgan et al. Jan 1973 A
3729182 Salvato Apr 1973 A
3760799 Crowson Sep 1973 A
3767195 Dimick Oct 1973 A
3828769 Mettler Aug 1974 A
3855638 Pilliar Dec 1974 A
3890953 Kraus et al. Jun 1975 A
3961380 Garr Jun 1976 A
3986212 Sauer Oct 1976 A
4037592 Kronner Jul 1977 A
4105017 Ryaby et al. Aug 1978 A
4108165 Kopp et al. Aug 1978 A
4127125 Takemoto et al. Nov 1978 A
4141524 Corvese, Jr. Feb 1979 A
4164794 Spector et al. Aug 1979 A
4170045 Estes Oct 1979 A
4176664 Talish Dec 1979 A
4195517 Kalinoski et al. Apr 1980 A
4206516 Pilliar Jun 1980 A
4216766 Duykers et al. Aug 1980 A
4227111 Cross et al. Oct 1980 A
4229992 McKee et al. Oct 1980 A
4233477 Rice et al. Nov 1980 A
4266532 Ryaby et al. May 1981 A
4266533 Ryaby et al. May 1981 A
4269797 Mikiya et al. May 1981 A
4291025 Pellico Sep 1981 A
4296753 Goudin Oct 1981 A
4312536 Lloyd Jan 1982 A
4315503 Ryaby et al. Feb 1982 A
4315514 Drewes et al. Feb 1982 A
4347645 Iseki Sep 1982 A
4351069 Ballintyn et al. Sep 1982 A
4355428 Deloison et al. Oct 1982 A
4358105 Sweeney, Jr. Nov 1982 A
4361154 Pratt, Jr. Nov 1982 A
4365359 Raab Dec 1982 A
4383533 Bhagat et al. May 1983 A
4407044 Iseki Oct 1983 A
4410158 Maffei Oct 1983 A
4421119 Pratt, Jr. Dec 1983 A
4431038 Rome Feb 1984 A
4440025 Hayakawa et al. Apr 1984 A
4441486 Pounds Apr 1984 A
4446586 Reed et al. May 1984 A
4452326 Hanssen et al. Jun 1984 A
4467659 Baumoel Aug 1984 A
4476847 Dunn Oct 1984 A
4476874 Taenzer et al. Oct 1984 A
4482942 Blaisdell et al. Nov 1984 A
4511921 Harlan et al. Apr 1985 A
4530360 Duarte Jul 1985 A
4536894 Galante et al. Aug 1985 A
4542539 Rowe, Jr. et al. Sep 1985 A
4542744 Barnes et al. Sep 1985 A
4550714 Talish Nov 1985 A
4556066 Semrow Dec 1985 A
4557148 Akiyama Dec 1985 A
4570487 Gruber Feb 1986 A
4570640 Barsa Feb 1986 A
4570927 Petrofsky et al. Feb 1986 A
4573996 Kwiatek et al. Mar 1986 A
4594662 Devaney Jun 1986 A
4612160 Donlevy et al. Sep 1986 A
4627429 Tsuk Dec 1986 A
4630323 Sage et al. Dec 1986 A
4644942 Sump Feb 1987 A
4646725 Moasser Mar 1987 A
4657543 Langer et al. Apr 1987 A
4669483 Hepp et al. Jun 1987 A
4677438 Michiguchi et al. Jun 1987 A
4680967 Rost Jul 1987 A
4687195 Potts Aug 1987 A
4689986 Carson et al. Sep 1987 A
4708127 Abdelghani Nov 1987 A
4710655 Masaki Dec 1987 A
4725272 Gale Feb 1988 A
4726099 Card Feb 1988 A
4763661 Sommer et al. Aug 1988 A
4770184 Greene, Jr. et al. Sep 1988 A
4774959 Palmer et al. Oct 1988 A
RE32782 Pratt, Jr. Nov 1988 E
4782822 Ricken Nov 1988 A
4787070 Suzuki et al. Nov 1988 A
4787888 Fox Nov 1988 A
4792336 Hlavacek et al. Dec 1988 A
4802477 Gabbay Feb 1989 A
4830015 Okazaki May 1989 A
4836316 Carnevale et al. Jun 1989 A
4855911 Lele et al. Aug 1989 A
4858599 Halpern Aug 1989 A
4867169 Machida et al. Sep 1989 A
4891849 Robinson Jan 1990 A
4905671 Senge et al. Mar 1990 A
4913157 Pratt, Jr. et al. Apr 1990 A
4917092 Todd et al. Apr 1990 A
4917376 Lo Apr 1990 A
4920966 Hon et al. May 1990 A
4926870 Brandenburger May 1990 A
4928959 Bassett et al. May 1990 A
4930358 Motegi et al. Jun 1990 A
4932951 Liboff et al. Jun 1990 A
4933230 Card et al. Jun 1990 A
4936303 Detwiler et al. Jun 1990 A
4941474 Pratt, Jr. Jul 1990 A
4947853 Hon Aug 1990 A
4979501 Valchanov et al. Dec 1990 A
4982730 Lewis, Jr. Jan 1991 A
4984462 Hass, Jr. et al. Jan 1991 A
4986275 Ishida et al. Jan 1991 A
4993413 McLeod et al. Feb 1991 A
4995883 Demane et al. Feb 1991 A
5000183 Bonnefous Mar 1991 A
5000442 Dalebout et al. Mar 1991 A
5003965 Talish et al. Apr 1991 A
5004476 Cook Apr 1991 A
5016641 Schwartz May 1991 A
5018285 Zolman et al. May 1991 A
5046484 Bassett et al. Sep 1991 A
5054490 Rossman et al. Oct 1991 A
5067940 Liboff et al. Nov 1991 A
5080672 Bellis Jan 1992 A
5088976 Liboff et al. Feb 1992 A
5099702 French Mar 1992 A
5100373 Liboff et al. Mar 1992 A
5103806 McLeod et al. Apr 1992 A
5106361 Liboff et al. Apr 1992 A
5107853 Plyter Apr 1992 A
5108452 Fallin et al. Apr 1992 A
5133420 Smith Jul 1992 A
5134999 Osipov Aug 1992 A
5139498 Astudillo Ley Aug 1992 A
5140988 Stouffer et al. Aug 1992 A
5143069 Kwon et al. Sep 1992 A
5143073 Dory Sep 1992 A
5154189 Oberlander Oct 1992 A
5163598 Peters et al. Nov 1992 A
5172692 Kulow et al. Dec 1992 A
5178134 Vago Jan 1993 A
5181512 Viebach et al. Jan 1993 A
5184605 Grzeszykowski Feb 1993 A
5186162 Talish et al. Feb 1993 A
5191880 McLeod et al. Mar 1993 A
5197475 Antich et al. Mar 1993 A
5201766 Georgette Apr 1993 A
5209221 Riedlinger May 1993 A
5211160 Talish et al. May 1993 A
5230334 Klopotek Jul 1993 A
5230345 Curran et al. Jul 1993 A
5230646 Thorup Jul 1993 A
5230921 Waltonen et al. Jul 1993 A
5235981 Hascoet et al. Aug 1993 A
5254123 Bushey Oct 1993 A
5259384 Kaufman et al. Nov 1993 A
5269306 Warnking et al. Dec 1993 A
5273028 McLeod et al. Dec 1993 A
5280728 Sato et al. Jan 1994 A
5284143 Rattner Feb 1994 A
5285788 Arenson et al. Feb 1994 A
5295931 Dreibelbis et al. Mar 1994 A
5301683 Durkan Apr 1994 A
5307284 Brunfeldt et al. Apr 1994 A
5309898 Kaufman et al. May 1994 A
5310408 Schryver et al. May 1994 A
5314401 Tepper May 1994 A
5316000 Chapelon et al. May 1994 A
5318561 McLeod et al. Jun 1994 A
5318779 Hakamatsuka et al. Jun 1994 A
5322067 Prater et al. Jun 1994 A
5323769 Bommannan et al. Jun 1994 A
5327890 Matura et al. Jul 1994 A
5330481 Hood et al. Jul 1994 A
5330489 Green et al. Jul 1994 A
5334214 Putnam Aug 1994 A
5339804 Kemp Aug 1994 A
5340510 Bowen Aug 1994 A
5351389 Erickson et al. Oct 1994 A
5363850 Soni et al. Nov 1994 A
5366465 Mirza Nov 1994 A
5367500 Ng Nov 1994 A
5368044 Cain et al. Nov 1994 A
5376065 McLeod et al. Dec 1994 A
5380269 Urso Jan 1995 A
5386830 Powers et al. Feb 1995 A
5393296 Rattner Feb 1995 A
5394877 Orr et al. Mar 1995 A
5394878 Frazin et al. Mar 1995 A
5398290 Brethour Mar 1995 A
5400795 Murphy et al. Mar 1995 A
5405389 Conta et al. Apr 1995 A
5409446 Rattner Apr 1995 A
RE34959 Potts May 1995 E
5413550 Castel May 1995 A
5415167 Wilk May 1995 A
5417215 Evans et al. May 1995 A
5424550 Kawano et al. Jun 1995 A
5425954 Thompson et al. Jun 1995 A
5431612 Holden Jul 1995 A
5434827 Bolorforosh Jul 1995 A
5441051 Hileman et al. Aug 1995 A
5441058 Fareed Aug 1995 A
5448994 Iinuma Sep 1995 A
5460595 Hall et al. Oct 1995 A
5466215 Lair et al. Nov 1995 A
5468220 Sucher Nov 1995 A
5476438 Edrich et al. Dec 1995 A
5478306 Stoner Dec 1995 A
5484388 Bassett et al. Jan 1996 A
5492525 Gibney Feb 1996 A
5495846 Uehara et al. Mar 1996 A
5496256 Bock et al. Mar 1996 A
5501657 Feero Mar 1996 A
5507800 Strickland Apr 1996 A
5507830 DeMane et al. Apr 1996 A
5509933 Davidson et al. Apr 1996 A
5520612 Winder et al. May 1996 A
5524624 Tepper et al. Jun 1996 A
5526815 Granz et al. Jun 1996 A
5541489 Dunstan Jul 1996 A
5547459 Kaufman et al. Aug 1996 A
5556372 Talish et al. Sep 1996 A
5578060 Pohl et al. Nov 1996 A
5615466 Safari et al. Apr 1997 A
5626554 Ryaby et al. May 1997 A
5626630 Markowitz et al. May 1997 A
5630837 Crowley May 1997 A
D380440 Talish et al. Jul 1997 S
5644093 Wright et al. Jul 1997 A
5648941 King Jul 1997 A
5656016 Ogden Aug 1997 A
5665141 Vago Sep 1997 A
5680863 Hossack et al. Oct 1997 A
5690608 Watanabe et al. Nov 1997 A
5691960 Gentilman et al. Nov 1997 A
5699803 Carodiskey Dec 1997 A
5702353 Guzzini et al. Dec 1997 A
5702389 Taylor et al. Dec 1997 A
5706818 Gondo Jan 1998 A
5708236 Shaanan et al. Jan 1998 A
5721400 Haraldsson et al. Feb 1998 A
5725482 Bishop Mar 1998 A
5728095 Taylor et al. Mar 1998 A
5730705 Talish et al. Mar 1998 A
5738625 Gluck Apr 1998 A
5741317 Ostrow Apr 1998 A
5743862 Izumi Apr 1998 A
5752924 Kaufman et al. May 1998 A
5755746 Lifshey et al. May 1998 A
5762616 Talish Jun 1998 A
5779600 Pape Jul 1998 A
5785656 Chiabrera et al. Jul 1998 A
5818149 Safari et al. Oct 1998 A
5829437 Bridges Nov 1998 A
5843741 Wong et al. Dec 1998 A
5856622 Yamamoto et al. Jan 1999 A
5868649 Erickson et al. Feb 1999 A
5871446 Wilk Feb 1999 A
5886302 Germanton et al. Mar 1999 A
5891143 Taylor et al. Apr 1999 A
5899425 Corey Jr. et al. May 1999 A
5904659 Duarte et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5954675 Dellagatta Sep 1999 A
5957814 Eschenbach Sep 1999 A
5962790 Lynnworth et al. Oct 1999 A
5971984 Taylor et al. Oct 1999 A
5997490 McLeod et al. Dec 1999 A
6019710 Dalebout et al. Feb 2000 A
6022349 McLeod et al. Feb 2000 A
6028066 Unger Feb 2000 A
6030386 Taylor et al. Feb 2000 A
6048323 Hon Apr 2000 A
6050943 Slayton et al. Apr 2000 A
6061597 Rieman et al. May 2000 A
6065350 Hill et al. May 2000 A
6068596 Weth et al. May 2000 A
6080088 Petersen et al. Jun 2000 A
6082181 Greenwood Jul 2000 A
6086078 Ferez Jul 2000 A
6088613 Unger Jul 2000 A
6093135 Huang Jul 2000 A
6105431 Duffill et al. Aug 2000 A
6165144 Talish et al. Dec 2000 A
6179797 Brotz Jan 2001 B1
6190336 Duarte et al. Feb 2001 B1
6206843 Iger et al. Mar 2001 B1
6213958 Winder Apr 2001 B1
6234975 McLeod et al. May 2001 B1
6234990 Rowe et al. May 2001 B1
6258020 Lopez Jul 2001 B1
6261221 Tepper et al. Jul 2001 B1
6261249 Talish et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6273864 Duarte Aug 2001 B1
6311402 Brandl et al. Nov 2001 B1
6322527 Talish Nov 2001 B1
6355006 Ryaby et al. Mar 2002 B1
6360027 Hossack et al. Mar 2002 B1
6394955 Perlitz May 2002 B1
6397683 Hagenmeyer et al. Jun 2002 B1
6406443 Talish Jun 2002 B1
6436060 Talish Aug 2002 B1
6443898 Unger Sep 2002 B1
6464687 Ishikawa et al. Oct 2002 B1
6503214 Talish Jan 2003 B1
6524261 Talish et al. Feb 2003 B2
6601597 Sung Aug 2003 B2
6685656 Duarte et al. Feb 2004 B1
6733468 Talish May 2004 B2
6932308 Talish et al. Aug 2005 B2
6960173 Babaev Nov 2005 B2
7108663 Talish Sep 2006 B2
7211060 Talish May 2007 B1
20020016557 Duarte Feb 2002 A1
20020068871 Mendlein et al. Jun 2002 A1
20020103448 Babaev Aug 2002 A1
20020115960 Redding, Jr. Aug 2002 A1
20020156400 Babaev Oct 2002 A1
20020190136 Babaev Dec 2002 A1
20030013956 Michaeli Jan 2003 A1
20030153848 Talish Aug 2003 A1
20030153849 Huckle Aug 2003 A1
20040127790 Lang et al. Jul 2004 A1
20050096548 Talish May 2005 A1
20060106424 Bachem May 2006 A1
20070208280 Talish Sep 2007 A1
Foreign Referenced Citations (45)
Number Date Country
19950292 Feb 2000 AU
1328485 Apr 1994 CA
3639263 Jun 1987 DE
4111055 Oct 1991 DE
19613425 Jan 1997 DE
29811185 Oct 1998 DE
0 181 506 May 1986 EP
331 348 Sep 1989 EP
0 425 765 May 1991 EP
0 536 875 Apr 1993 EP
0 679 371 Nov 1995 EP
0 695 559 Feb 1996 EP
0 965 839 Dec 1999 EP
2156983 Oct 1985 GB
2277448 Nov 1994 GB
2 303 552 Feb 1997 GB
SHO 62-47359 Mar 1987 JP
HEI 4-82567 Mar 1992 JP
HEI 4-82568 Mar 1992 JP
HEI 4-82569 Mar 1992 JP
HEI 5-269159 Oct 1993 JP
WO 8503449 Aug 1985 WO
WO 8800845 Feb 1988 WO
WO 8802250 Apr 1988 WO
WO 9006720 Jun 1990 WO
WO 9413411 Jun 1994 WO
WO 9503744 Feb 1995 WO
WO 9533416 Dec 1995 WO
WO 9625112 Aug 1996 WO
WO 9625888 Aug 1996 WO
WO 9733649 Sep 1997 WO
WO 9810729 Mar 1998 WO
WO 9829036 Jul 1998 WO
WO 9834578 Aug 1998 WO
WO 9847570 Oct 1998 WO
WO 9918876 Apr 1999 WO
WO 9922652 May 1999 WO
WO 9948621 Sep 1999 WO
WO 9956829 Nov 1999 WO
WO 9958080 Nov 1999 WO
WO 0003663 Jan 2000 WO
WO 0028925 May 2000 WO
WO 0067846 Nov 2000 WO
WO 0071207 Nov 2000 WO
WO 0076406 Dec 2000 WO
Related Publications (1)
Number Date Country
20020016557 A1 Feb 2002 US
Divisions (1)
Number Date Country
Parent 08886217 Jul 1997 US
Child 09273214 US
Continuations (2)
Number Date Country
Parent 09273214 Mar 1999 US
Child 09928594 US
Parent 08799240 Feb 1997 US
Child 08886217 US